| Segment Information During the three months ended June 30, 2023, the Company renamed its Industrial segment as "Technologies."
The following table summarizes select operating results for each reportable segment (in millions).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
| Revenues |
|
|
|
|
|
|
|
| Medical |
$ |
74.1 |
|
|
$ |
68.8 |
|
|
$ |
214.1 |
|
|
$ |
203.2 |
|
| Technologies |
132.7 |
|
|
122.4 |
|
|
392.4 |
|
|
367.3 |
|
| Consolidated revenues |
$ |
206.8 |
|
|
$ |
191.2 |
|
|
$ |
606.5 |
|
|
$ |
570.5 |
|
| Segment Income (Loss) from Operations |
|
|
|
|
|
|
|
| Medical |
$ |
4.0 |
|
|
$ |
4.0 |
|
|
$ |
10.4 |
|
|
$ |
1.6 |
|
| Technologies |
14.7 |
|
|
5.4 |
|
|
45.8 |
|
|
23.7 |
|
| Total segment income from operations |
18.7 |
|
|
9.4 |
|
|
56.2 |
|
|
25.3 |
|
| Corporate and other |
(20.3) |
|
|
(20.5) |
|
|
(60.4) |
|
|
(60.6) |
|
| Consolidated loss from operations |
$ |
(1.6) |
|
|
$ |
(11.1) |
|
|
$ |
(4.2) |
|
|
$ |
(35.3) |
|
The Company’s assets by reportable segment were not included, as this information is not reviewed by, nor otherwise provided to, the chief operating decision maker to make operating decisions or allocate resources.
The following details revenues by geographic region. Revenues generated from external customers are attributed to geographic regions through sales from site locations (i.e., point of origin) (in millions).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
Three Months Ended September 30, |
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
| North America |
|
|
|
|
|
|
|
| Medical |
$ |
67.7 |
|
|
$ |
62.1 |
|
|
$ |
194.3 |
|
|
$ |
185.0 |
|
| Technologies |
70.9 |
|
|
69.8 |
|
|
192.1 |
|
|
189.1 |
|
| Total North America |
138.6 |
|
|
131.9 |
|
|
386.4 |
|
|
374.1 |
|
| Europe |
|
|
|
|
|
|
|
| Medical |
6.5 |
|
|
6.7 |
|
|
19.8 |
|
|
18.2 |
|
| Technologies |
58.8 |
|
|
50.7 |
|
|
190.3 |
|
|
167.2 |
|
| Total Europe |
65.3 |
|
|
57.4 |
|
|
210.1 |
|
|
185.4 |
|
| Asia Pacific |
|
|
|
|
|
|
|
| Medical |
— |
|
|
— |
|
|
— |
|
|
— |
|
| Technologies |
2.9 |
|
|
1.9 |
|
|
10.0 |
|
|
11.0 |
|
| Total Asia Pacific |
2.9 |
|
|
1.9 |
|
|
10.0 |
|
|
11.0 |
|
| Total revenues |
$ |
206.8 |
|
|
$ |
191.2 |
|
|
$ |
606.5 |
|
|
$ |
570.5 |
|
The following details revenues by timing of recognition (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
Three Months Ended September 30, |
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
| Point in time |
$ |
149.5 |
|
|
$ |
128.0 |
|
|
$ |
427.0 |
|
|
$ |
371.1 |
|
| Over time |
57.3 |
|
|
63.2 |
|
|
179.5 |
|
|
199.4 |
|
| Total revenues |
$ |
206.8 |
|
|
$ |
191.2 |
|
|
$ |
606.5 |
|
|
$ |
570.5 |
|
The following details revenues by product category (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
Three Months Ended September 30, |
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
| Medical segment: |
|
|
|
|
|
|
|
| Medical |
$ |
74.1 |
|
|
$ |
68.8 |
|
|
$ |
214.1 |
|
|
$ |
203.2 |
|
| Technologies segment: |
|
|
|
|
|
|
|
| Reactor Safety and Control Systems |
54.5 |
|
|
48.7 |
|
|
163.1 |
|
|
141.9 |
|
| Radiological Search, Measurement, and Analysis Systems |
78.2 |
|
|
73.7 |
|
|
229.3 |
|
|
225.4 |
|
| Total revenues |
$ |
206.8 |
|
|
$ |
191.2 |
|
|
$ |
606.5 |
|
|
$ |
570.5 |
|
|